These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12592140)

  • 1. Delayed tc-99m sestamibi washout in graves' disease.
    Balan KK; Baltrop AH; Wishart GC
    Clin Nucl Med; 2003 Mar; 28(3):239-40. PubMed ID: 12592140
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of hypercalcaemic crisis secondary to coexistence of primary hyperparathyroidism and Graves' disease.
    Baldane S; Ipekci SH; Evcen R; Gedik GK; Guler I; Kebapcilar L
    Endocr Regul; 2016 Oct; 50(4):225-228. PubMed ID: 27941175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Localization of parathyroid adenomas].
    Mjåland O; Normann E; Halvorsen E; Rynning S
    Tidsskr Nor Laegeforen; 2003 Mar; 123(5):648-50. PubMed ID: 12683196
    [No Abstract]   [Full Text] [Related]  

  • 4. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
    Leslie WD; Dupont JO; Bybel B; Riese KT
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [99m Tc-sestamibi in the diagnosis of the location of hyperparathyroidism].
    Berná Roqueta L
    Rev Esp Med Nucl; 1998; 17(2):102-11. PubMed ID: 9611280
    [No Abstract]   [Full Text] [Related]  

  • 6. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
    Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
    J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of technetium Tc 99m sestamibi for detection of a parathyroid adenoma in a dog with primary hyperparathyroidism.
    Matwichuk CL; Taylor SM; Wilkinson AA; Dudzic EM; Matte GG; Outerbridge CA; Schmon CL; Ihle SL
    J Am Vet Med Assoc; 1996 Nov; 209(10):1733-6. PubMed ID: 8921031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient false-negative tc-99m sestamibi parathyroid scintigraphy following total thyroidectomy.
    Rubello D; Maffei P; Pelizzo MR; Martini C; De Carlo E; Piotto A; Rampin L; Shapiro B; Sicolo N
    Clin Nucl Med; 2005 Jul; 30(7):528-9. PubMed ID: 15965341
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the isotopic localization of parathyroid adenomas].
    García Pérez I; Pozo Fidalgo F; Ricarte Pérez P; García-Morán M
    Rev Esp Med Nucl; 2002 Apr; 21(2):126-7. PubMed ID: 11879624
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Tc-99m MIBI and TI-201/Tc-99m pertechnetate for diagnosis of primary hyperparathyroidism.
    Rauth JD; Sessions RB; Shupe SC; Ziessman HA
    Clin Nucl Med; 1996 Aug; 21(8):602-8. PubMed ID: 8853910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior bulge sign for parathyroid adenoma on Tc-99m MIBI SPECT.
    Bajoghli M; Muthukrishnan A; Mountz JM
    Clin Nucl Med; 2006 Aug; 31(8):470-1. PubMed ID: 16855433
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preoperative localization of parathyroid adenomas using Tc-99m-sestamibi].
    Stilgren LS; Diemer H
    Ugeskr Laeger; 1996 Mar; 158(13):1832-4. PubMed ID: 8650759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of intraoperative parathyroid hormone monitoring with false-positive sestamibi scintigraphy.
    Inabnet WB; Rayfield EJ; Kim CK
    Thyroid; 2002 Sep; 12(9):833-4. PubMed ID: 12481951
    [No Abstract]   [Full Text] [Related]  

  • 15. The value of sestamibi scans.
    Hodin R
    Surgery; 2002 Feb; 131(2):238-9. PubMed ID: 11854713
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
    Taillefer R; Boucher Y; Potvin C; Lambert R
    J Nucl Med; 1992 Oct; 33(10):1801-7. PubMed ID: 1328564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative localization of a parathyroid adenoma with Tc-99m sestamibi imaging in a patient with concomitant nontoxic multinodular goiter.
    Zuback J; Patel KA; Guzman R; Thakur N; Zonszein J
    Clin Nucl Med; 1995 Jan; 20(1):27-30. PubMed ID: 7895432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid imaging with technetium-99m labelled cationic complexes: which tracer and which technique should be used?
    Lind P
    Eur J Nucl Med; 1997 Mar; 24(3):243-5. PubMed ID: 9143459
    [No Abstract]   [Full Text] [Related]  

  • 19. A retroesophageal parathyroid adenoma detected with Tc-99m sestamibi and MRI.
    Zentner J; Vogt H; Heidenreich P
    Clin Nucl Med; 1999 Dec; 24(12):998-9. PubMed ID: 10595493
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences between technetium-99m tetrofosmin and technetium-99m sestamibi in parathyroid scintigraphy.
    Giordano A; Meduri G
    Eur J Nucl Med; 1997 Mar; 24(3):347. PubMed ID: 9143476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.